GL1X · GenesisL1 explorer

Research workbench

Fxr with cdca and ncoa-2 peptide

Analyse Fxr with cdca and ncoa-2 peptide in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4QE6
Type
protein
Length
241 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Bile acid receptor; Nuclear receptor coactivator 2
UniProt
Q96RI1, Q15596
Ligands
JN3
Pockets
2 · best druggability 0.83

Structure

x-ray diffraction · 2 distinct chains · 69% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABile acid receptorprotein22870% helix, 0% strandQ96RI1
BNuclear receptor coactivator 2protein1362% helix, 0% strandQ15596

Ligands and binding sites

  • JN3 · Chenodeoxycholic acid · ligand · chains A
  • EDO · 1,2-ethanediol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14680.830.9053JN3
21870.490.7622empty

Interfaces

1 interface between chains.

  • A–B · 624 Ų buried · 12 hydrogen bonds · protein-protein

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.